Lacticaseibacillus Rhamnosus

ATC — · 1 markets · 1 records

Lacticaseibacillus Rhamnosus 1 markets · 1 records Forms
Filters
MarketUS 1
Kind

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

Combination products containing this ingredient

  • 217 mgcapsule CombinationLacticaseibacillus Rhamnosus 217 mg + Lactiplantibacillus Plantarum 217 mg + Lactobacillus Acidophilus 217 mg + Lessonia Nigrescens 20 mg + Limosilactobacillus Fermentum 217 mg + Limosilactobacillus Reuteri 217 mgMicrovara
The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.